Announcement of the resolution of the first extraordinary General Meeting of shareholders in 2024

release time:

2024-02-20 10:15

AnnouncementNumber: 2024-008

Stock code: 832316                      Securities abbreviation: Tim Zheng Biotech                 Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd

Announcement of the resolution of the first extraordinary General Meeting of shareholders in 2024

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

 

1. The convening and attendance of the meeting
(1) Information on the convening of the meeting
1. Date of the meeting: February 19, 2024
2. Meeting place: Conference room on the third floor of the company
3. Meeting method: √ On-site voting □ Network voting □ Other voting methods
4. Convenor: Board of Directors
5. Meeting Moderator: Mr. CAI Tiyuan, Chairman
6. Explanation of legality and compliance of the convening situation:
The convening and holding of this general meeting of shareholders is in accordance with the Company Law, Securities Law and other relevant laws, administrative regulations, departmental rules, normative documents and the provisions of the Articles of Association.
(2) Attendance at the meeting
A total of 6 shareholders attended or authorized to attend the general meeting, holding a total of 62,028,068 shares of voting rights, accounting for 54.89% of the total number of voting shares of the Company.
(3) The attendance of directors, supervisors and senior managers of the company at shareholders' meetings without voting rights
1. The company has 5 directors in office and 5 non-voting participants;
2. There are 3 supervisors in the company and 3 non-voting participants;
3. The secretary of the board of directors of the company attended the meeting;
4. Senior management of the company attended the meeting.

 

2. Deliberation of bills

(1) Deliberating and passing the motion on the Company's Plan to Change the Accounting Firm
1. Contents of the motion:
In view of the future development needs of the company, in order to better promote the audit work of the company, after comprehensive evaluation, the company intends to change the accounting firm and appoint Zhongxi Accounting Firm (special general partnership) as the audit institution of the company's annual report in 2023, responsible for the audit of the company's financial report.
2. Motion voting result:
62,028,068 ordinary shares agreed, representing 100% of the total number of voting shares at the shareholders' meeting; The number of opposing shares is 0 shares, accounting for 0% of the total number of voting shares at the shareholders' meeting; The number of abstentions is 0 shares, accounting for 0% of the total number of voting shares at the shareholders' meeting.
3. Recusal from voting
None.
 

3. File directory for reference
Resolution of the First Extraordinary Shareholders' Meeting of Jilin Tianzheng Biotechnology Co., LTD in 2024
 

 

 

Jilin Tianzheng Biotechnology Co., LTD
Board of directors
February 19, 2024